Back to Trades
Xia Yu
DirectorCIK 0001963544
Profile
- Filings
- 2
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Xia Yu, Director, has filed 2 SEC reports (2025–2026), all concentrated in Summit Therapeutics Inc. (SMMT), totaling $10.6M in disclosed volume. Weighing $10.0M bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $10.0M in Summit Therapeutics Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.